Literature DB >> 7594554

CD66 family members are associated with tyrosine kinase activity in human neutrophils.

K M Skubitz1, K D Campbell, K Ahmed, A P Skubitz.   

Abstract

The granulocyte activation Ags, CD66a, CD66b, CD66c, and CD66d, are expressed at low levels on resting blood granulocytes, but their surface expression is up-regulated following stimulation. CD66a, in contrast to CD66b and CD66c which are anchored to the membrane via a glycosyl-phosphatidylinositol linkage, is a transmembrane protein with a cytoplasmic domain. We have previously reported that CD66a is phosphorylated in human neutrophils, largely on tyrosine, with a lower level of phosphoserine. We have now found that CD66a undergoes a rapid increase in phosphorylation following stimulation with FMLP, platelet-activating factor, and 12-O-tetradecanoyl-phorbol-13-acetate. This increase in phosphorylation was transient, with maximal phosphorylation observed by 1 min and a return to base line by 5 min following stimulation. Protein kinase activity was detected in neutrophils associated with CD66a, CD66b, and CD66c. Most of the protein kinase activity associated with these Ags was tyrosine kinase activity, with a lesser amount of threonine and serine kinase activities. Lyn and Hck accounted for much of the associated tyrosine kinase activity. The data suggest that phosphorylation of CD66a on tyrosine by an associated tyrosine kinase may play a role in the function of CD66a. In addition, associated tyrosine kinase activity may play a role in signal transduction from CD66a, CD66b, and CD66c to regulate other cell functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594554

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Tyrosine phosphatase SHP-1 is involved in CD66-mediated phagocytosis of Opa52-expressing Neisseria gonorrhoeae.

Authors:  C R Hauck; E Gulbins; F Lang; T F Meyer
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 2.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of Rho-like GTPases.

Authors:  S Sadekova; N Lamarche-Vane; X Li; N Beauchemin
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

4.  Defining the roles of human carcinoembryonic antigen-related cellular adhesion molecules during neutrophil responses to Neisseria gonorrhoeae.

Authors:  Helen Sarantis; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

5.  Distinct mechanisms of internalization of Neisseria gonorrhoeae by members of the CEACAM receptor family involving Rac1- and Cdc42-dependent and -independent pathways.

Authors:  Oliver Billker; Andreas Popp; Volker Brinkmann; Gerald Wenig; Jutta Schneider; Emmanuelle Caron; Thomas F Meyer
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

Review 6.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  CD66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes.

Authors:  S D Gray-Owen; C Dehio; A Haude; F Grunert; T F Meyer
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

Review 8.  CEACAM1 structure and function in immunity and its therapeutic implications.

Authors:  Walter M Kim; Yu-Hwa Huang; Amit Gandhi; Richard S Blumberg
Journal:  Semin Immunol       Date:  2019-04       Impact factor: 11.130

Review 9.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Perturbation of lytic and latent gammaherpesvirus infection in the absence of the inhibitory receptor CEACAM1.

Authors:  Heiko Adler; Susanne El-Gogo; Simone Guggemoos; Wolfgang Zimmermann; Nicole Beauchemin; Robert Kammerer
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.